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PCongenital Heart Disease
Hypoplastic Left Heart Syndrome
Links to Chromosomes 10q and 6q and
Is Genetically Related to Bicuspid Aortic Valve
Robert B. Hinton, MD,* Lisa J. Martin, PHD,†‡ Smitha Rame-Gowda, PHD,*
Meredith E. Tabangin, MPH,‡ Linda H. Cripe, MD,* D. Woodrow Benson, MD, PHD*
Cincinnati, Ohio
Objectives This study was designed to identify disease loci for hypoplastic left heart syndrome (HLHS) and evaluate the ge-
netic relationship between HLHS and bicuspid aortic valve (BAV).
Background Previously, we identified that HLHS and BAV exhibit complex inheritance, and both HLHS and BAV kindreds are
enriched for BAV. However, the genetic basis of HLHS and its relationship to BAV remains unclear.
Methods Family-based nonparametric genome-wide linkage analysis was performed in kindreds ascertained by either an
HLHS or BAV proband. Echocardiograms were performed on 1,013 participants using a sequential sampling
strategy (33 HLHS kindreds, 102 BAV kindreds).
Results The recurrence risk ratio of BAV in HLHS families (8.05) was nearly identical to that in BAV families (8.77). Link-
age to chromosomal regions 10q22 and 6q23 with maximum logarithm of odds scores of 3.2 and 3.1, respec-
tively, was identified in HLHS kindreds. In addition, 5 suggestive loci were identified (7q31, 11q22, 12q13,
14q23, and 20q11). We previously identified loci at chromosomes 18q22, 13q34, and 5q21 in BAV kindreds.
The relationship between these loci was examined in the combined HLHS and BAV cohort and associations be-
tween loci were demonstrated (5q21, 13q34, and 14q23; 6q23 and 10q22; 7q31 and 20q11). Subsequent
subsets linkage analysis showed a significant improvement in the logarithm of odds score at 14q23 only
(4.1, p  0.0001).
Conclusions These studies demonstrate linkage to multiple loci identifying HLHS as genetically heterogeneous. Subsets linkage
analyses and recurrence risk ratios in a combined cohort provide evidence that some HLHS and BAV are genetically
related. (J Am Coll Cardiol 2009;53:1065–71) © 2009 by the American College of Cardiology Foundation













vypoplastic left heart syndrome (HLHS) (MIM [Mende-
ian Inheritance in Man] database #241550) is a severe form
f cardiovascular malformation (CVM) and continues to be
significant cause of infant mortality and childhood mor-
idity (1). The frequent occurrence of left- and right-sided
alve dysplasia in HLHS probands and the presence of
icuspid aortic valve (BAV) (MIM #109730) in family
embers suggests that HLHS is a severe form of valve
alformation (2). This conclusion is supported by the
bservation that HLHS is part of the in utero natural
istory of aortic stenosis (3). Hypoplastic left heart syn-
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ccepted December 3, 2008.rome has been linked with several cytogenetic abnormali-
ies including Turner and Jacobsen syndromes, and het-
rozygous mutations in NKX2.5 and GJA1 have been
eported in a small number of cases (4,5). However, the
enetic basis of HLHS remains largely unknown. Several
tudies have implicated a primary genetic basis and autoso-
al recessive inheritance has been suggested (6,7). Herita-
ility analysis of HLHS and associated CVM suggests that
LHS is determined largely by genetic effects but exhibits
complex inheritance (2).
See page 1072
Bicuspid aortic valve is the most common CVM and occurs in
pproximately 1% (0.4% to 2.25%) of the general population (8).
icuspid aortic valve is a risk factor for aortic valve disease and
nderlies the diseased valve in the majority of the 100,000 aortic
alve replacement procedures performed annually in the U.S. (9).
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inheritance (12). Based on studies
showing that kindreds ascertained
by a proband with either HLHS
or BAV are enriched for BAV
(2,7,10,13), a genetic relationship
between HLHS and BAV has been
speculated.
Pedigree analyses have been
interpreted as indicating simple
Mendelian inheritance of HLHS
(6) and BAV (14). Although car-
diovascular genetics is steeped in
xamples of genetic discovery using model-based ap-
roaches, such as atrial septal defect (15), the phenomena of
enetic heterogeneity, reduced penetrance, and variable
xpressivity underscore that even what seems to be simple
nheritance is complex because genotype does not predict
henotype, that is, a single gene does not explain inheri-
ance. Our results (2,12) and those of others (16,17) have
uestioned simple Mendelian inheritance of HLHS and
AV, implicating them as complex traits.
The purpose of this study was to identify loci for HLHS
nd define the genetic relationship between HLHS and
AV. Given the complex inheritance of HLHS and BAV,
e performed nonparametric family-based genome-wide
inkage analysis. Hypoplastic left heart syndrome linked to
uman chromosomal regions 10q22 and 6q23 with maxi-
um logarithm of odds (LOD) scores of 3.2 and 3.1,
espectively, identifying HLHS as genetically heteroge-
eous. In the combined HLHS and BAV cohort, a locus on
4q23 exhibited significant linkage (LOD 4.1). Taken
ogether, these findings suggest that some HLHS and BAV
re genetically related.
ethods
tudy population. Two family-based cohorts were ascer-
ained independently by identifying probands with either
LHS or BAV and were recruited from the Cardiology Clinic
t Cincinnati Children’s Hospital Medical Center (2,10). A
omplete medical history and blood sample was obtained from
ach participant. Cross-sectional 2-dimensional and Doppler
ransthoracic echocardiography were used in a sequential sam-
ling strategy as previously described (2,10). This protocol was
pproved by the Institutional Review Board of Cincinnati
hildren’s Hospital Medical Center. Informed consent was
btained from all participants.
roband inclusion and exclusion criteria. Probands had
LHS or BAV as previously defined (2,10). We used a
trict (BAV only or HLHS only) and broad (BAV or
LHS and/or associated CVM) definition of affected
tatus; these phenotypes were defined before the genetic
nalysis. Patients with complex CVM and left ventricular
Abbreviations
and Acronyms




HLHS  hypoplastic left
heart syndrome
LOD  logarithm of odds
VEGF  vascular
endothelial growth factorypoplasia (e.g., unbalanced atrioventricular septal defect) ar a known genetic syndrome (e.g., Turner syndrome or
acobsen syndrome) were excluded (2).
enotyping. Methods for whole blood sample collection and
eoxyribonucleic acid extraction as well as genotyping (using
he ABI Linkage Mapping set version 2.5 MD10 [Applied
iosystems, Carlsbad, California]), allele calling (using Gen-
Mapper software version 3.1 [Applied Biosystems]), and
hecking for Mendelian inconsistencies (using Infer procedure
n PEDSYS [Southwest Foundation for Biomedical Research,
an Antonio, Texas]) have been previously described (12).
fter data cleaning,95% of genotypes were used in analyses.
arshfield sex-averaged genetic maps were used for marker
ap positions (18). Allele frequencies were calculated based on
articipant’s genotype data using SOLAR version 4.1 (Se-
uential Oligogenic Linkage Analysis Routines, San Antonio,
exas).
inkage analysis. Because HLHS and BAV exhibit com-
lex inheritance and model misspecification limits the
ower to detect linkage, we used nonparametric methods,
hich rely on allele sharing rather than inheritance mode
19,20). Sample prevalence was constrained to be equal to
he general population prevalence to correct for ascertain-
ent bias. The HLHS prevalence is0.02%, and BAV and
ther CVM are each 1% (8). Linkage analyses were
un using a prevalence of 2% for HLHS, BAV, and
ssociated CVM.
The null hypothesis (no linkage) was tested by comparing
he likelihood of this model with that of a linkage model
21). The difference between the log10 likelihoods of these
odels produces a LOD score, a measure of linkage
trength. The SOLAR software was used to adjust LOD
cores to ensure they appropriately reflected the p value
22,23). This procedure simulates a fully informative un-
inked marker and tests trait linkage at that marker to
etermine the null LOD score distribution. Empirical
values were estimated as: (number of replicates with LOD
qualing or exceeding a specified LOD  1)/(number of
eplicates simulated  1) (24). Ten thousand simulations
ere performed; the LOD score was adjusted to reflect the
nderlying null distribution (i.e., LOD 3.0 is equivalent to
 0.001). Significant linkage was considered present
hen LOD 3.0 and suggestive linkage when LOD 2.0.
onfirmation of loci. To confirm loci, we searched for
egions that exhibited at least suggestive linkage (LOD
2.0) in 1 cohort (HLHS or BAV) and reached a p value
f at least 0.05 (LOD 1.3) in the other cohort (25,26).
ased on current and previous results, we tested for confir-
ation to loci on chromosomes 5q21, 6q23, 7q31, 10q22,
1q22, 12q13, 13q34, 14q23, 18q22, and 20q11.
ubsets linkage analysis. As multiple loci were identified
n both cohorts, we were concerned about locus heteroge-
eity; therefore, we used subsets linkage analysis to deter-
ine whether reducing locus heterogeneity would improve
inkage in the combined cohort. To determine regions likely
o benefit from subsets analysis, we performed regression
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March 24, 2009:1065–71 HLHS and BAV Are Genetically Related0 loci that demonstrated suggestive linkage in either
ohort. To minimize false positives, we used Bonferroni
orrection to adjust for the 45 tests performed (p  0.05/45
0.001). Regions with family-specific LODs that exhib-
ted significant associations (p  0.001) with other regions
ere selected for subsets analysis.
Subsets linkage analysis was performed in 1 of 2 ways.
irst, ordered subsets analysis was performed using FLOSS
flexible ordered subset analysis) (28). Ordered subsets
nalysis uses covariate information to identify a homoge-
ous subset of families that yields increased linkage evi-
ence. Second, subsets were selected based on an a priori
eighting scheme. When there was positive association,
amilies exhibiting a family-specific LOD 0.1 at the
econd (predictor) region were given a weight of 1 and all
thers a weight of 0. When there was a negative association,
amilies exhibiting a family specific LOD 0.1 at the
econd region were given a weight of 1 and all others a
eight of 0. This weighting scheme is more conservative
han the weighting scheme proposed by Cox et al. (27),
hich used a cutoff of 0 instead of 0.1. For both methods,
ignificance is assessed using permutation.
ecurrence risk ratio. The BAV recurrence risk ratios
R) were calculated for first-degree relatives in both HLHS
nd BAV cohorts. Recurrence risk ratio was defined as:
R  fr/fp, where fr is the number of affected first-degree
elatives over the number of first-degree relatives, and fp is
he general population BAV prevalence (1%) (29).
esults
henotype characterization: HLHS cohort. We evalu-
ted 208 individuals in 33 families identified by an HLHS
roband (Table 1). Phenotypes in some families were
reviously reported (2). In 52% of families, there was more
han 1 affected individual. In addition to the 33 probands
24 male, 9 female), 38 other family members had 1 or more
VMs, including 4 with HLHS. Valve abnormalities were
istribution of HLHS and AssociatedVM in 33 Families (208 Individuals)
Table 1 Distribution of HLHS and AssociatedCVM in 33 Families (208 Individuals)
Male Female Total
HLHS 25 12 37
Valve disease 19 6 25
Aortic valve 18 6 24
BAV 11 2 13
Other abnormality 7 4 11
Mitral valve 1 0 1
Valve surgery 2 1 3
Aortic 1 1 2
Mitral 1 0 1
Aortic root dilation 0 3 3
Other CVM 8 6 14
n the HLHS cohort, there were 71 affected individuals. The number of phenotypes exceeds the
umber of individuals because some individuals had more than 1 CVM.
BAV bicuspid aortic valve; CVM cardiovascular malformation; HLHS hypoplastic left heart
yndrome.ommon (30%), including 24 with aortic valve abnormalities
n13 BAV) and 1 with myxomatous changes and mitral valve
rolapse. Of the 3 individuals with a dilated aortic root, 1
lso had an aortic valve malformation. Other CVMs were
bserved in 14 family members, including aortic coarctation
n 5), ventricular septal defect (n 3), atrial septal defect
n  2), fatal unspecified cyanotic CVM as newborn (n 
), atrioventricular septal defect (n  1), persistent truncus
rteriosus (n  1), and left superior vena cava (n  1).
henotype characterization: BAV cohort. In a separate
ohort of 102 families identified by a proband with BAV,
05 individuals were evaluated (Table 2). Phenotypes in
ome families were previously reported (10,12). In 56% of
amilies, there was more than 1 affected individual. Among
he 102 probands (73 male, 29 female), BAV was either
solated (n  69) or combined with aortic coarctation (n 
2), dilated aortic root (n  10), ventricular septal defect
n  5), abnormal mitral valve (n  5), atrial septal defect
n  3), subaortic stenosis (n  2), left superior vena cava
n  2), abnormal tricuspid valve (n  1), or endocardial
broelastosis (n  1). Eighteen probands had a history of
ortic valve surgery or balloon valvuloplasty. Among 805
articipants, 231 had 1 or more CVMs, including 3 with
LHS. Valve abnormalities were common (63%), includ-
ng 156 with BAV. An abnormal (e.g., valve thickening,
usp redundancy, or eccentric valve closure [10]) but tricus-
id aortic valve was present in 32 individuals. Dilated aortic
oot was present in 27 individuals, including 13 who also
ad an abnormal aortic valve. Mitral valve abnormalities
ere observed in 18 individuals, including 8 who also had an
bnormal aortic valve. In some participants, aortic (n  35)
r mitral (n  5) surgery was performed.
inkage analysis: HLHS cohort. Linkage analyses using
he broad (HLHS and associated CVM) phenotype are
resented. Linkage analyses using the strict (HLHS only)
henotype demonstrated the same patterns of linkage;
owever, the identified linkage signals were attenuated and
id not reach statistical significance (data not shown).
mong 33 HLHS families, 2 significant loci (LOD 3)
ere identified (Fig. 1). The pedigrees of the 10 families
istribution of BAV and AssociatedVM in 102 Families (805 Ind viduals)
Table 2 Distribution of BAV and AssociatedCVM in 102 Families (805 Individuals)
Male Female Total
Valve disease 138 68 206
Aortic valve 130 58 188
BAV 111 45 156
Other abnormality 19 13 32
Mitral valve 8 10 18
Valve surgery 28 11 39
Aortic 27 8 35
Mitral 1 3 4
Aortic root dilation 21 6 27
HLHS 3 0 3
Other CVM 33 17 50
n the BAV cohort, there were 231 affected individuals. The number of phenotypes exceeds the
umber of individuals because some individuals had more than 1 CVM.
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HLHS and BAV Are Genetically Related March 24, 2009:1065–71ontributing to the 2 significant HLHS loci are shown in
igure 2. The maximum LOD scores for significant loci
ere 3.2 on chromosome 10q22.1 near marker D10S537 and 3.1
n chromosome 6q23.3 near marker D6S292 (Fig. 3). In addi-
Figure 1 Multipoint LOD Scores From Nonparametric Linkage A
The x axis designates the chromosomes using proportional spacing. The y axis ind
significant linkage, and the dotted line at LOD 2.0 indicates evidence of suggestiv
suggestive linkage peaks were identified (7q31, 11q22, 12q13, 14q23, and 20q1
regions (16q24 and 20q13) (arrows). CVM  cardiovascular malformation; HLHS
Figure 2 Pedigrees Depicting 10 Kindreds Contributing to Link
Darkened quadrants indicate phenotype including HLHS (left upper), abnormal aortic
and coarctation of the aorta (COA) (left lower), and other CVM (right lower). An arrow
symbol indicates phenotype status unknown. ASD  atrial septal defect; AVSD  atri
as newborn; LSVC  left superior vena cava; MVA  mitral valve abnormality; VSD ion, 5 suggestive linkage peaks (LOD 2) were identified
n chromosomes 7q31.2 (D7S486; LOD 2.7), 11q22.1
D11S898; LOD 2.4), 12q13.1 (D12S368; LOD 2.2),
4q23.2 (D14S63; LOD 2.1), and 20q12 (D20S107; LOD
es Across the Genome for HLHS and Associated CVM
the nonparametric LOD score. The solid line at LOD 3.0 indicates evidence of
ge. Two significant linkage peaks were identified (6q23 and 10q22) (*), and 5
). There were 2 additional suggestive linkage peaks identified on telomeric
oplastic left heart syndrome; LOD  logarithm of odds.
t Chromosomes 6q23 and 10q22
ncluding bicuspid aortic valve (right upper), aortopathy including dilated aorta (AOD)
tes the proband. An open symbol indicates normal cardiac anatomy and a gray
cular septal defect; CCVM  fatal unspecified cyanotic cardiovascular malformation
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March 24, 2009:1065–71 HLHS and BAV Are Genetically Related.0). Two additional suggestive loci were identified on
hromosomes 16q24.1 (D16S520; LOD 2.6) and 20q13.33
D20S173; LOD 2.6); however, enthusiasm for these loci
as diminished because the peaks were identified in inter-
als without flanking markers (e.g., telomeric regions),
hich are prone to false-positive linkage (30).
Given the presence of multiple linkage peaks, we exam-
ned each family’s contribution to the loci. Family-specific
OD scores ranged from –0.21 to 0.91 and –0.37 to 1.2,
or chromosomes 6q23.3 and 10q22.1, respectively. Using a
utoff of 0.1 LOD units, 7 of 33 (21%) families contributed
o each of the peaks on chromosomes 6 and 10 (Fig. 4).
our families contributed to both peaks, consistent with
omplex inheritance of HLHS. Taken together, these
ndings identify 2 significant HLHS loci and demonstrate
hat HLHS is genetically heterogeneous.
inkage analysis and confirmation: BAV cohort. In 38
AV families, we previously identified linkage to chromo-
ome 18q22, 13q34, and 5q21 (12). The results of the
urrent study including an additional 64 BAV families (total
02 BAV families) did not identify new significant or
uggestive loci, but continued to show evidence of linkage to
Figure 3 Multipoint LOD Scores From
Nonparametric Linkage Analyses in HLHS Kindreds
Chromosomes 6q23 (A) and 10q22 (B) exhibit significant linkage. The vertical
lines represent the upper and lower bound of the 1-LOD unit support interval.
Abbreviations as in Figure 1.8q22 and 5q21. Only 1 HLHS locus, 14q23, was con-rmed in the BAV cohort (15 BAV families in addition to
he original 6 HLHS families). The 1-LOD unit support
nterval of the BAV cohort (LOD 1.5) overlapped the
LHS locus (Fig. 5A). The BAV loci were not identified in
he HLHS cohort.
ssociation between loci using family-specific LOD
cores. Regressing the family-specific LOD scores, we found
everal statistically associated regions including 14q23 with
3q34 (beta  0.49  0.10, p  0.0001) and 5q21 (beta 
.41  0.09, p  0.0001), 6q23 with 10q22 (beta  0.22 
.07, p  0.001), and 7q31 with 20q12 (beta  0.27  0.07,
 0.0001). Association between family-specific LOD scores
dentifies loci that co-segregate within families providing
vidence that information at 1 locus is associated in part with
nother locus suggesting interaction. These related loci may
dentify regions in which subsets linkage analysis improves
inkage evidence.
ubsets linkage analysis: combined cohort. To reduce the
mpact of locus heterogeneity, we performed subsets linkage
nalyses; we limited analysis to regions exhibiting signifi-
antly associated family-specific LOD scores to minimize
alse-positive associations. This approach strengthened
inkage at the 14q23 locus. Ordered subsets analysis using
Figure 4 Family-Specific LOD Scores Exceeding
0.1 LOD at Chromosomes 6q23 and 10q22
Family identification numbers in the overlapping area of the 2 circles indicate
families contributing to both linkage peaks. The table presents only those fami-
lies contributing at least 0.1 logarithm of odds (LOD) units. Therefore, the family-
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HLHS and BAV Are Genetically Related March 24, 2009:1065–71ither family-specific LOD scores at chromosomes 5 and 13
id not statistically improve the LOD score. However,
hen we incorporated information from both variables by
aking the residuals from a regression of the family-specific
ODs at 5 and 13 (n  10 families), there was a significant
mprovement in the LOD (p  0.0001), increasing the
OD from 1.6 in the combined cohort to 3.2. Using the a
riori weighting scheme (n  121 families), there was a
ignificant improvement in the LOD (p  0.0001) increas-
ng to 4.1 (Fig. 5B).
enetic relationship between HLHS and BAV. In addi-
ion to the shared locus on chromosome 14, the recurrence
isk ratio (R) for BAV is nearly identical in the 2 indepen-
ently ascertained cohorts. The R in HLHS families was
.05, which is consistent with previous findings (2), and was
imilar to the R of 8.77 found in BAV families. In
ddition, 1 HLHS family includes a set of monozygotic
wins with discordant phenotypes; 1 twin has HLHS and
he other has isolated BAV. These findings, together with
he observation of individuals with BAV in the HLHS
Figure 5 Linkage to Chromosome
14q23 in the HLHS and BAV Cohorts
The original suggestive linkage peak (LOD 2) was identified in the HLHS
cohort (dashed line) and confirmed (LOD 1.3) in the bicuspid aortic valve
(BAV) cohort (dotted line) (A). The horizontal arrows represent 1-LOD unit sup-
port intervals with the overlapping region shown in yellow. In the combined
cohort, linkage at 14q23 (dotted-dashed line) was strengthened using subsets
linkage analysis (solid line) (B). NPL  nonparametric logarithm of odds; other
abbreviations as in Figure 1.indreds and individuals with HLHS in the BAV kindreds wTables 1 and 2), support a genetic relationship between
LHS and BAV.
iscussion
sing family-based linkage analysis, 2 significant loci on
0q22 and 6q23 were identified providing evidence that
onsyndromic HLHS is genetically heterogeneous. A sig-
ificant proportion of kindreds (21%) contributed to each
ocus, suggesting these loci account for a substantial number
f HLHS cases. Further, a suggestive HLHS locus on
1q22 has been previously described (31) in a case of HLHS
ith a balanced translocation t (10;11) (q24;q23), externally
alidating these analyses. Loci at chromosome 10q22 and
q23 are gene-rich, containing approximately 300 positional
andidate genes. Based on the speculation that HLHS is a
evere form of valve malformation (2), we anticipate
isease-causing genes to be involved in valvulogenesis.
owever, because HLHS and BAV exhibit complex inher-
tance, identifying their genetic basis may require discover-
ng a genetic variation at multiple loci.
To identify genomic regions that encode genes influencing
he complex inheritance of HLHS and BAV, we used non-
arametric, family-based genome-wide linkage analysis. This
pproach was chosen rather than population-based association
nalysis for several reasons. First, several multiplex families
ere identified, making linkage analysis feasible. Second, with
ssociation-based methods, linkage disequilibrium becomes
npredictable with rare single nucleotide polymorphisms. Fur-
hermore, many genes implicated in CVM exhibit different
utations in different families (allelic heterogeneity), for ex-
mple, NKX2.5 and TBX5 (19). Allelic heterogeneity reduces
ower to detect associations, further limiting the value of
ssociation for genetic studies of CVM. Therefore, linkage
nalysis was used to search for loci in kindreds identified by
LHS or BAV probands. Like other complex conditions,
otably mitral valve prolapse (32), the finding of multiple
nconfirmed significant loci may result from phenotypic im-
recision or false-positive linkage peaks in addition to locus
eterogeneity. Subsets linkage analysis is one strategy to deal
ith genetic heterogeneity.
The VEGF gene is a growth factor that regulates several
ndothelial cell functions including proliferation and differen-
iation, and the vascular endothelial growth factor (VEGF)
athway is an important signaling module in heart valve
evelopment (33). Although VEGF is not encoded at any loci
dentified in this study, several VEGF pathway members are.
or example, HIF-1, encoded at 14q23, is a signaling molecule
n the VEGF pathway; other VEGF pathway members
nclude genes encoded at 14q23 (PGF, ACTN1, and EIF2) as
ell as genes encoded at other loci (e.g., VCL at 10q22).
ecause HLHS and BAV exhibit complex inheritance, iden-
ification of the genetic basis of these phenotypes may require
mutation analysis of coding sequence as well as regulatory
equence that may alter expression and/or interaction of path-
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March 24, 2009:1065–71 HLHS and BAV Are Genetically Relatedequired for analysis of other genetic discovery methods used to
ssess these complex traits, such as comparative genomic
ybridization and genome-wide association study.
Identification of shared chromosomal loci for HLHS and
AV provides the first direct evidence of a genetic relation-
hip between HLHS and BAV. However, only a limited
umber of HLHS and BAV families share loci (21 of 135,
6%), and the majority of linkage peaks including the
trongest HLHS and BAV loci could not be confirmed in
he combined cohort. Although this may reflect power
imitations in the current study, this finding suggests that
he genetic relationship between all “left-sided” CVMs may
ot be as strong as has been presumed (17).
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